Navigation Links
Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011

SAUSALITO, Calif., Sept. 22, 2011 /PRNewswire/ -- Sanovas Inc., a leading developer of minimally invasive technologies for the diagnosis and treatment of pulmonary disease and lung cancer, today announced that CEO and co-founder Larry Gerrans will speak at AdvaMed 2011, the industry's premier medical technology conference taking place Sept. 26-28, 2011 in Washington, D.C. Mr. Gerrans, an industry veteran, will be participating in an interactive panel addressing the challenges and lessons learned as a CEO in the medical device industry.  

Mr. Gerrans has served in executive leadership and consulting roles in the life sciences at Depuy Orthopedics (Johnson & Johnson), Stryker Corp., Smith & Nephew Corp., and the Sorin Group. He is widely recognized as one of the founders and developers of the Endoscopic Surgical Suite (Endo-Suite) and the Digital Operating Room, today's most technologically advanced operating rooms. Mr. Gerrans pioneered the development of the medical industry's first voice-activation technology for surgical device control in the operating theater. He has led the business and product development of minimally invasive surgical techniques, technologies and implant systems for orthopedics, general surgery, gynecology, ENT, cardiac and urology. Mr. Gerrans has participated in most of the major advances in surgical devices.  

"I have experienced first-hand the challenges of developing and commercializing innovative technologies, managing a start-up enterprise and raising money," said Sanovas CEO Larry Gerrans. "I value the opportunity to share my insights at AdvaMed and to hear the experiences of other entrepreneurs as we grow our companies and create new technologies that will advance healthcare."

The panel "Ask the CEO: Life as an Entrepreneur... and Beyond!" will be moderated by Semprus BioSciences CEO and co-founder David Lucchino. Joining Mr. Gerrans on the panel are William Hawkins, former CEO and chairman of Medtronic, and James Pachence, a well-known entrepreneur and executive at medical device, pharmaceutical and biotech companies. The panel begins at 5:30 p.m. local time at the Walter E. Washington Convention Center at 801 Mount Vernon Place NW, in Washington, D.C. The panel concludes AdvaMed's Entrepreneurship Boot Camp, which will run on Monday, Sept. 26 starting at 1 p.m. Eastern Daylight Time.

AdvaMed 2011 ( is North America's premier medical technology, business development, policy forum and capital formation event, sponsored by industry trade group AdvaMed. AdvaMed's member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies.

About Sanovas

Sanovas is a leading-edge product development engine providing innovative minimally invasive solutions to the surgical and interventional sciences. Sanovas' technology provides the surgeon with intuitive command of the operating environment utilizing new innovations that advance technology and operative intelligence. Sanovas' "Smart Technologies" employ revolutionary advances in Access, Imaging, Resection, Drug Delivery, Physiologic Metric Acquisition & Biofeedback to create proprietary solutions that provide surgeons with a faster, less invasive, lower risk and more cost-effective alternative to current treatment interventions. To find out more please visit


Marla Kertzman for Sanovas
(415) 694-6701

SOURCE Sanovas Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Larry King to Host 10th Annual American Friends of Rabin Medical Center Broadway on the Hudson Gala
2. AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage
3. ProUroCare Medical Elects Larry W. Getlin as New Director
4. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
5. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
6. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
7. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
8. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
9. Genta Clinical Programs Featured at American Society of Hematology Meeting
10. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
11. UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
Breaking Medicine News(10 mins):